226 hedge funds and large institutions have $1.72B invested in Genmab in 2020 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 85 increasing their positions, 63 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

14% more funds holding

Funds holding: 198226 (+28)

1.83% more ownership

Funds ownership: 62.58%64.42% (+1.8%)

4% more call options, than puts

Call options by funds: $3.57M | Put options by funds: $3.44M

Holders
226
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.57M
Puts
$3.44M
Net Calls
Net Calls Change

Top Buyers

1 +$21.9M
2 +$14.9M
3 +$14.4M
4
Jennison Associates
Jennison Associates
New York
+$14.2M
5
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$11.4M

Top Sellers

1 -$18.3M
2 -$14.3M
3 -$14.1M
4
Morgan Stanley
Morgan Stanley
New York
-$13.2M
5
Artisan Partners
Artisan Partners
Wisconsin
-$12.9M
Name Holding Trade Value Shares
Change
Change in
Stake
176
$36.6K
177
$33K
178
$33K
179
$32K
180
$28K
181
$26K
182
$24.8K
183
$24K
184
$23K
185
$22K
186
$20K
187
$20K
188
$19K
189
$16K
190
$16K
191
$15K
192
$14K
193
$13K
194
$10K
195
$9K
196
$9K
197
$9K
198
$8K
199
$7K
200
$6K